top of page
Search

The Role of Advocacy in Clinical Trials and Why It Is No Longer Optional

  • Bridgepoint Clinical Communications
  • Mar 21
  • 3 min read

Clinical trials are the foundation of medical advancement.

They bring new therapies to market, improve patient outcomes, and shape the future of healthcare. But behind every protocol, dataset, and regulatory submission is something far more important:


The participant.

And yet, in many cases, the participant’s voice is the least represented in the research process. This is where advocacy becomes essential.


At Bridgepoint Clinical, we believe that advocacy is not an added layer to clinical research. It is a core function that directly impacts trust, access, and outcomes.


What Does Advocacy in Clinical Trials Really Mean?

Advocacy in clinical research goes beyond recruitment and retention.

It is the active, intentional representation of participant needs, concerns, and experiences throughout the lifecycle of a study.

It means asking:

  • Are we designing studies that people can realistically participate in?

  • Are we communicating in a way that is clear, respectful, and culturally relevant?

  • Are we removing barriers, or unintentionally creating them?

Advocacy ensures that participants are not just included in research, but considered, respected, and supported at every stage.


The Gap in Traditional Clinical Research Models

Historically, clinical trials have been designed from a scientific and operational perspective, with limited input from the populations they aim to serve.

This has led to:

  • Low participation from underrepresented communities

  • High dropout rates

  • Mistrust in the research process

  • Limited real-world applicability of results

Without advocacy, research risks becoming disconnected from the very people it is meant to help.


Why Advocacy Is Critical Now

The clinical research industry is evolving.

Regulatory bodies like the U.S. Food and Drug Administration are emphasizing diversity, transparency, and participant protection more than ever before.

Communities are demanding:

  • Greater inclusion

  • More transparency

  • Ethical accountability

  • Respect for their lived experiences

Advocacy is the bridge between these expectations and successful study execution.


Advocacy Improves More Than Ethics, It Improves Outcomes

When advocacy is embedded into clinical trials, the impact is measurable.

Stronger Recruitment--Participants are more likely to enroll when they feel seen, understood, and valued.

Higher Retention--When participant needs are addressed, they are more likely to stay engaged throughout the study.

Better Data Quality--Engaged participants lead to more reliable and complete data.

Increased Trust--Advocacy builds long-term relationships between research organizations and communities.

Advocacy is not just about doing what is right. It is about doing what works.

What Advocacy Looks Like in Practice

Effective advocacy in clinical trials includes:

  • Incorporating participant feedback into study design

  • Simplifying and improving informed consent processes

  • Addressing social determinants that impact participation

  • Providing support services such as transportation or flexible scheduling

  • Ensuring culturally competent communication and engagement

  • Creating ongoing feedback loops throughout the study

It is a continuous process, not a one-time effort.


The Role of Bridgepoint Clinical

At Bridgepoint Clinical, advocacy is at the center of our approach.

We work with sponsors, CROs, and research sites to ensure that participant perspectives are not overlooked, but integrated into every phase of the study.

We help organizations:

  • Identify gaps in participant experience

  • Design participant-centered strategies

  • Strengthen trust with diverse communities

  • Align operations with both regulatory expectations and real-world needs


Our work is rooted in the understanding that clinical research is not just about protocols. It is about people.


The Bottom Line

Without advocacy, clinical trials risk being efficient, but ineffective.

They may meet timelines, but fail to reach the populations that need them most.

They may generate data, but lack relevance in the real world.

Advocacy changes that.

It ensures that research is not only scientifically sound, but also equitable, accessible, and impactful.


Let’s Redefine Clinical Research Together

At Bridgepoint Clinical, we are committed to advancing a model of research that prioritizes both innovation and humanity.

Because when participants are truly supported, research does more than succeed.

It makes a difference.

 
 
 

Comments


© 2026 by Bridgepoint Clinical

bottom of page